EPA TRI Facility · Chemicals
Pacira Pharmaceuticals Inc
San Diego, CA · Parent: Pacira Pharmaceuticals Inc
- Total releases
- 293 lbs
- Chemicals reported
- 1
- Carcinogens
- 1
- Primary pathway
- Off-site Transfers
Pacira Pharmaceuticals Inc is an EPA Toxics Release Inventory reporter in San Diego, CA, in the chemicals sector. It reported 16 lbs of releases across 1 chemical in 2023, and 293 lbs in total across its 2019-2023 reporting years. That ranks 15,391 of 25,986 TRI facilities nationwide by cumulative reported pounds, counting each facility over however many years it has filed. Pounds reported are not a measure of toxicity or health risk. Nearest other TRI reporters: Pall Filtration & Separations Group Inc; Integrated Dna Technologies; Miramar Plant 33; Illumina. Similar-scale Chemicals peers outside California: Chase Corp-Pittsburgh; Alex C Fergusson LLC; Wampum Hardware Co.; Chemicals Inc Bay City Site. Largest disclosed chemicals by pounds: Dichloromethane.
Pacira Pharmaceuticals Inc has reported 293 lbs of toxic releases across 1 chemical to the EPA Toxic Release Inventory, based on annual facility disclosures from 2019 through 2023. Of the chemicals reported, 1 is classified as carcinogen, representing 100% of the facility's chemical profile. The facility operates in the Chemicals sector. The primary release pathway is off-site transfers, accounting for 75% of total releases. All release data shown below is self-reported to the EPA under the Emergency Planning and Community Right-to-Know Act (EPCRA) Section 313.
Pacira Pharmaceuticals Inc vs. every reporting TRI facility
Cumulative reported release pounds, with this facility marked in the national distribution
293 lbs 41st percentile higher than 41% of 25,986 reporting TRI facilities
Each bar is a $1M-wide band; taller bars hold more reporting TRI facilities. The dashed line and filled bar mark this facility. Hover, focus, or tap a bar for its full count, share, and position.
Source U.S. Environmental Protection Agency, Toxics Release Inventory · 2023 reporting year
Where this facility sits in the TRI record
Among the 3,917 Chemicals facilities in this database, Pacira Pharmaceuticals Inc reports the 3,042nd-largest volume (293 lbs).
Placement is computed from reported TRI pounds in this database. Thresholds are fixed across every facility page: concentrated ≥60% of volume in one chemical, county-dominant ≥25% of the county total, carcinogen-heavy ≥50% of pounds. Share-based statements are shown only for sites reporting at least 1,000 lbs, because a share of a very small total is not a meaningful signal. Reported pounds are self-reported estimates and do not measure toxicity or health risk.
Pacira Pharmaceuticals Inc files annual Form R disclosures to the EPA Toxics Release Inventory under EPCRA Section 313, classified under NAICS 325412 (Chemicals). Across 5 years of records spanning 2019–2023, the site has disclosed 293 lbs in cumulative toxic releases across 1 distinct chemical, 1 of which (100%) carry a carcinogenic classification. Largest chemicals by pounds: Dichloromethane.
The dominant release pathway is off-site transfers at 219 lbs (74.7% of total volume), followed by air releases at 25.3%. Between 2019 and 2023, reported totals decreased by 93% - from 235 lbs to 16 lbs. The facility is operated under parent company Pacira Pharmaceuticals Inc. Nearest other TRI reporters: Pall Filtration & Separations Group Inc; Integrated Dna Technologies; Miramar Plant 33; Illumina. Similar-scale peers outside California: Chase Corp-Pittsburgh; Alex C Fergusson LLC; Wampum Hardware Co.; Chemicals Inc Bay City Site.
TRI Form R values are self-reported estimates, not measured stack emissions, and treat every pound of reported chemical equally regardless of toxicity. Inclusion in the TRI database does not establish a health risk to nearby residents; it documents the annual reporting record that Pacira Pharmaceuticals Inc has filed with the EPA under federal community right-to-know requirements - open Pall Filtration & Separations Group Inc for a different chemical mix before treating volume as risk.
Quick Facts
Compare this facility
See how Pacira Pharmaceuticals Inc stacks up against nearby facilities and the typical reporter.
5.9× more than the comparison
50% less than the comparison
Comparison reflects reported pounds and chemical counts, not toxicity or health risk. Averages cover facilities reporting any release.
How does this facility release toxic chemicals?
How Pacira Pharmaceuticals Inc releases toxic chemicals into the environment. Total: 293 lbs.
Emissions Trend Summary
From 2019 to 2023, total releases decreased by 93% (235 lbs to 16 lbs).
Reported total releases by year
Pacira Pharmaceuticals Inc - annual TRI totals
- 2019 0
2019
0 million lbs
- 2020 0
2020
0 million lbs
- 2021 0
2021
0 million lbs
- 2022 0
2022
0 million lbs
- 2023 0
2023
0 million lbs
What this shows Year-over-year reported totals. TRI figures are self-reported estimates and can swing with production levels, waste-rock handling and reporting changes, not only with emissions controls.
| Year | Total | Chemicals |
|---|---|---|
| 2019 | 235 lbs | 1 |
| 2020 | 15 lbs | 1 |
| 2021 | 14 lbs | 1 |
| 2022 | 13 lbs | 1 |
| 2023 | 16 lbs | 1 |
Chemical Releases
Aggregated across all reporting years (2019–2023). 1 of 1 chemicals are carcinogens. Sorted by total release volume.
| Chemical | Total | Flags |
|---|---|---|
| Dichloromethane | 293 lbs | Carcinogen |
Location
Nearest TRI Facilities to Pacira Pharmaceuticals Inc
Closest other reporters in California - including Pall Filtration & Separations Group Inc, Integrated Dna Technologies, Miramar Plant 33, ordered by distance.
Similar Chemicals Facilities
Other Chemicals facilities with similar total release volumes (±80%), outside California - e.g. Chase Corp-Pittsburgh, Alex C Fergusson LLC, Wampum Hardware Co..
About TRI Data
Data as of 2023 reporting year. Source: U.S. Environmental Protection Agency (EPA) Toxic Release Inventory.
Data comes from the EPA Toxic Release Inventory (TRI) program. Facilities that manufacture, process, or otherwise use listed toxic chemicals above threshold amounts are required to report annually to the EPA.
On this page the largest disclosed chemicals include Dichloromethane; nearby reporters include Pall Filtration & Separations Group Inc. "Total releases" includes air, water, land, and off-site transfers for disposal, aggregated across available reporting years. Quantities are self-reported estimates, not measured stack emissions.
PlainEnviro presents this data without advocacy framing. The presence of a facility in the TRI database does not by itself indicate a health risk. For site-specific health questions, consult your local environmental or health agency.
Frequently Asked Questions
What chemicals does Pacira Pharmaceuticals Inc release? ▼
What industry is Pacira Pharmaceuticals Inc in? ▼
How does Pacira Pharmaceuticals Inc compare with other TRI facilities? ▼
How long has Pacira Pharmaceuticals Inc reported to the TRI? ▼
How does Pacira Pharmaceuticals Inc release toxic chemicals? ▼
Are emissions from Pacira Pharmaceuticals Inc increasing or decreasing? ▼
Is Pacira Pharmaceuticals Inc a health risk? ▼
Does Pacira Pharmaceuticals Inc release carcinogens? ▼
Explore More Data for California
What to do with this facility's data
From Pacira Pharmaceuticals Inc, open Pall Filtration & Separations Group Inc or Chase Corp-Pittsburgh next rather than reading rank alone.
- See whether releases reported by Pacira Pharmaceuticals Inc are rising or falling over time (watch Dichloromethane in the chemical mix). View trends
- Compare Pacira Pharmaceuticals Inc with nearby reporter Pall Filtration & Separations Group Inc before treating rank as risk. Open Pall Filtration & Separations Group Inc
- Cross-check similar-scale peer Chase Corp-Pittsburgh outside California. Open Chase Corp-Pittsburgh
Rank and named neighbors (Pall Filtration & Separations Group Inc, Integrated Dna Technologies) are disclosure volume only, not toxicity-weighted risk or enforcement status.
Read our methodology - how this data is sourced, computed, and verified.
Related
Sources & how this page was built
Every figure on this page traces to public, federal-government data on Pacira Pharmaceuticals Inc. The records below are the primary sources; our methodology explains how they are joined, computed, and verified.
- EPA Toxics Release Inventory (TRI) Basic Data Files - annual self-reported chemical-release filings. epa.gov
- EPA TRI Program, chemical & reporting reference - what each chemical is and how releases are counted. epa.gov
- EPA Facility Registry Service (FRS) - authoritative facility location and identity. epa.gov
- EPA Enforcement & Compliance History Online (ECHO) - regulatory and compliance context. echo.epa.gov
- EPA Envirofacts - the EPA data warehouse that exposes these datasets. enviro.epa.gov
Retrieved and formatted by PlainEnviro. TRI release totals are self-reported estimates, not measured stack emissions.
According to the U.S. Environmental Protection Agency, the Toxics Release Inventory has required annual industrial disclosure since its creation under the Emergency Planning and Community Right-to-Know Act in October 1986, and this facility's record is drawn from PlainEnviro's database of more than 25,000 EPA-tracked facilities through the 2023 reporting year; see our methodology for full source citations and refresh cadence.